Go Therapeutics

GO! Astellas picks up partner in convertibleCAR for backloaded $780M antibody project
Fierce Biotech
Wed, 06/1/22 - 09:53 am
Astellas
immuno-oncology
R&D
Go Therapeutics
glycoprotein targets
GO Therapeutics Enters into a License Agreement with Roche Worth up $195 Million for Cancer Treatment
CP Wire
Tue, 10/2/18 - 12:02 pm
Roche
Go Therapeutics
drug development
bispecific antibodies
GO Therapeutics Enters into a License Agreement with Roche Worth up $195 Million for Cancer Treatment
Tue, 10/2/18 - 09:58 am
Go Therapeutics
Roche